Cited by 259Nicotinic Acetylcholine Receptors StudyAlkaloids: synthesis and pharmacologyReceptor Mechanisms and Signaling

Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit

Papke, R L, Heinemann, S F·1994·Molecular Pharmacology

Abstract

As previously reported by Luetje and Patrick [J. Neurosci. 11:837-845 (1991)], the nicotine-like alkaloid cytisine is relatively ineffective in evoking current responses from nicotinic receptors containing the beta 2 subunit. In our experiments, the responses of alpha 4 beta 2- and alpha 3 beta 2-injected oocytes to the application of 1 mM cytisine were only 14.7 +/- 4% and 2.5 +/- 0.8% of the responses to 1 mM acetylcholine (ACh), respectively. Concentration-response relationships for ACh were examined in the presence and absence of cytisine. Although cytisine was relatively ineffective in stimulating current, the coapplication of cytisine and ACh reduced the responses to ACh. For alpha 4 beta 2 receptors, 3 microM cytisine shifted the dose-response curve for ACh to the right, resulting in a 60-fold increase in the apparent EC50 for ACh. For alpha 3 beta 2 receptors, 30 microM cytisine shifted the apparent EC50 for ACh from approximately 150 microM to 1 mM. Although the efficacy of cytisine for alpha 3 beta 2 receptors was very low, cytisine could effectively inhibit the responses of these receptors, with an IC50 of approximately 10 microM. The efficacy of cytisine for alpha 4 beta 2 receptors was greater than that for alpha 3 beta 2 receptors, and it was possible to evaluate the partial agonist properties of cytisine for these receptors. Although the EC50 of cytisine for stimulating current through alpha 4 beta 2 receptors was about 1 microM, concentrations of cytisine as low as 20 nM were able to inhibit 50% of the response to 1 microM ACh. The inhibitory effects of cytisine were reversible over a period of 5 min. Our analysis suggests that cytisine is a true partial agonist for beta 2-containing ACh receptors and as such can inhibit the response of these receptors to ACh through a competitive mechanism. In the case of alpha 4 beta 2 receptors cytisine binds with high apparent affinity and low efficacy to a site shared with ACh, and for alpha 3 beta 2 receptors both the apparent affinity and efficacy of cytisine are relatively low.

Integrity signals

Registry

Crossref · 10.1016/s0026-895x(25)09896-7

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Varenicline is a derivative of cytisine, a plant alkaloid with selective affinity and partial agonism for α4β2 nAChRs.

    “It is a derivative of cytisine, a plant alkaloid with selective affinity and partial agonism for α4β2 nAChRs [236–238].”

    From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [236]

The citation lists haven’t been fetched yet

Cited by 259

Authors
Papke, R. L., & Heinemann, S. F.
Affiliations
Salk Institute for Biological Studies (US)
Venue
Molecular Pharmacology
Publisher
Elsevier BV
Published
1994-01
Volume
45
Issue
1
Pages
142-149
ISSN
0026-895X (ISSN-L)
OpenAlex
W1715524310
Cited by
259
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 6 · 2020: 2 · 2019: 3 · 2018: 8 · 2017: 7 · 2016: 4 · 2015: 7 · 2014: 6 · 2013: 10 · 2012: 9
FWCI
2.66
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed
Funders
  • National Institutes of Health (5r01ns011549-24)
  • National Institute of Neurological Disorders and Stroke (NS11549)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
cytisine, neuronal nicotinic acetylcholine receptors, beta2 subunit, partial agonists, acetylcholine, competitive inhibition, receptor binding affinity, receptor efficacy
MeSH terms
Quinolizidine Alkaloids, Acetylcholine, Alkaloids, Animals, Azocines, Binding Sites, Neurons, Quinolizines, Receptors, Nicotinic, Xenopus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review